SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016504-08-000009
Filing Date
2008-02-22
Accepted
2008-02-22 17:05:14
Documents
16
Period of Report
2008-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 inb8k_20080222.htm 8-K 23957
2 exhibit3_1.htm EX-3 102300
3 exhibit10_1.htm EX-10 187270
4 exhibit10_2.htm EX-10 48314
5 exhibit10_3.htm EX-10 27283
6 exhibit10_4.htm EX-10 129013
7 exhibit10_5.htm EX-10 64141
8 exhibit10_6.htm EX-10 88581
9 exhibit10_7.htm EX-10 169764
10 exhibit10_8.htm EX-10 50285
11 exhibit10_9.htm EX-10 29193
12 exhibit10_10.htm EX-10 94883
13 exhibit99_1.htm EX-99 7012
14 GRAPHIC image002.gif GRAPHIC 5044
15 GRAPHIC image004.gif GRAPHIC 14215
16 exhibit10_11.htm EX-10 71721
  Complete submission text file 0001016504-08-000009.txt   1122228
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 133035216 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 08637228
SIC: 2834 Pharmaceutical Preparations